Researchers found that more socially involved female baboons had higher reproductive success rates and lower infant mortality. This contradicts the long-held assumption that social relationships are only beneficial for mothers.
Scientists discover conditions for cracks to propagate supersonically in brittle solids, challenging classical theories on fracture speed. Hyperelasticity governs dynamic fracture under extreme deformation, with a characteristic length scale near the crack tip.
Researchers at Duke University Medical Center have discovered two genetic regions linked to heart function and survival in patients with heart failure. The study found that genetic variations on chromosomes 13, 18, 2, and 4 affect cardiac function and survival, providing potential targets for new therapies.
Two independent studies successfully selected and expanded gene-corrected human stem cells using a novel drug-resistance gene. This breakthrough may be useful in human clinical trials of gene therapy for bone marrow transplantation settings. Additionally, upregulation of Irs2 promotes beta cell growth, survival, and insulin secretion, ...
Research finds that heavy use of analgesics for at least nine years prior to irreversible kidney failure is associated with anatomic changes of SICK. Over 7% of dialysis patients had SICK, with 33% having overused analgesics preceding dialysis start.
A new study by the Society for Women's Health Research has found that spleen cells can rapidly regrow adult islet cells without embryonic stem cells. This breakthrough discovery opens up a new approach to treating Type 1 diabetes, which develops when the immune system attacks insulin-producing islet cells.
The GRAM program combines data sets on gene regulatory pathways and messenger RNA levels to determine causal relationships between regulators and genes. By processing these data sets together, researchers can identify regulators that switch genes on or off across the entire genome.
Researchers from NCAR's Research Applications Program developed the NCAR Efficient Spectral Processing Algorithm (NESPA) to aid pilots in navigating turbulent storms. The algorithm achieved an impressive accuracy rate of over 80%, detecting turbulence encounters with very few false positives.
A randomized study found that physostigmine reduces sleep-disordered breathing in patients with moderate to severe obstructive sleep apnea, particularly during REM sleep. The results suggest a possible new treatment for the condition.
A study analyzing 62 movies across four continents found that epilepsy is often stereotyped, with males shown as violent and females as exotic and vulnerable. The dramatic potential of seizures may contribute to these portrayals.
Researchers found naked mole-rats naturally lack Substance P, a neurotransmitter that sends pain signals to the central nervous system. Introducing Substance P restored pain signaling in these animals, sparking hope for new therapies to treat fibromyalgia.
Researchers have linked genetic factors to severe kidney disease in blacks, with evidence pointing to genes on chromosome 18 and another unidentified region. The study involved a large African-American cohort and could pave the way for targeted therapies.
A new study suggests that maternal circulating cells can migrate to the heart of infants, potentially causing a damaging immune response. The research, led by Dr. Anne Stevens, found that these cells were present at higher levels in the hearts of babies with neonatal lupus syndrome, which can cause severe heart damage.
Researchers successfully transferred and expressed MGMT into relatively few hematopoietic stem cells using a lentivirus vector, enabling gene-corrected cells to repopulate the hematopoietic compartment. This breakthrough has significant implications for human clinical trials of gene therapy in bone marrow transplantation settings.
Researchers discovered that mantis shrimp use fluorescent markings to enhance signaling in deep, blue ocean waters. The stomatopod's characteristic spots fluoresce yellow-green to increase visibility in the dim light.
A Phase II study found dronabinol significantly reduced behavioral agitation in patients with Alzheimer's disease. The medication also improved caregivers' burden and daily living skills.